Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Epidemiology of autoimmune and inflammatory diseases in a French Nationwide HIV cohort.

Lebrun D, Hentzien M, Cuzin L, Rey D, Joly V, Cotte L, Allavena C, Dellamonica P, Servettaz A, Bani-Sadr F; and the Dat’AIDS study group.

AIDS. 2017 Jul 18. doi: 10.1097/QAD.0000000000001603. [Epub ahead of print]

PMID:
28723711
2.

[Sarcoidosis occurring after chemotherapy for breast cancer: Difficulty of drug causality assessment].

Didier K, Beguinot I, Abou-Taam M, Servettaz A, Bani-Sadr F.

Therapie. 2017 May 26. pii: S0040-5957(17)30086-0. doi: 10.1016/j.therap.2017.05.001. [Epub ahead of print] French. No abstract available.

PMID:
28647105
3.

Prognostic factors associated with 30-day in-hospital mortality in coagulase-negative Staphylococcus bacteraemia: no impact of vancomycin minimum inhibitory concentration.

Hentzien M, Strady C, Vernet-Garnier V, Servettaz A, De Champs C, Delmer A, Bani-Sadr F, N'Guyen Y.

Infect Dis (Lond). 2017 Sep;49(9):664-673. doi: 10.1080/23744235.2017.1323346. Epub 2017 May 11.

PMID:
28490261
4.

Atypical presentation of paroxysmal nocturnal hemoglobinuria treated by eculizumab: A case report.

Quinquenel A, Maestraggi Q, Lecoq-Lafon C, Peffault de Latour R, Delmer A, Servettaz A.

Medicine (Baltimore). 2017 Mar;96(12):e6403. doi: 10.1097/MD.0000000000006403.

5.

[Systemic lupus erythematosus presenting as severe alveolar hypoventilation and the shrinking lung syndrome].

Ammar Y, Launois C, Perotin JM, Dury S, Servettaz A, Perdu D, Vallerand H, Nardi J, Boulagnon-Rombi C, Pluot M, Lebargy F, Deslee G.

Rev Mal Respir. 2017 May;34(5):571-575. doi: 10.1016/j.rmr.2016.10.875. Epub 2017 Feb 8. French.

PMID:
28189434
6.

Imbalance of the Vanin-1 Pathway in Systemic Sclerosis.

Kavian N, Mehlal S, Marut W, Servettaz A, Giessner C, Bourges C, Nicco C, Chéreau C, Lemaréchal H, Dutilh MF, Cerles O, Guilpain P, Vuiblet V, Chouzenoux S, Galland F, Quere I, Weill B, Naquet P, Batteux F.

J Immunol. 2016 Oct 15;197(8):3326-3335. Epub 2016 Sep 19.

PMID:
27647831
7.

Interpretation of serological tests in the diagnosis of celiac disease: Anti-deamidated gliadin peptide antibodies revisited.

Zucchini L, Giusti D, Gatouillat G, Servettaz A, Tabary T, Barbe C, Pham BN.

Autoimmunity. 2016 Sep;49(6):414-420. Epub 2016 Jul 23.

PMID:
27452003
8.

Bevacizumab to Treat Cholangiopathy in Hereditary Hemorrhagic Telangiectasia: Be Cautious: A Case Report.

Maestraggi Q, Bouattour M, Toquet S, Jaussaud R, Kianmanesh R, Durand F, Servettaz A.

Medicine (Baltimore). 2015 Nov;94(46):e1966. doi: 10.1097/MD.0000000000001966.

9.

Pantethine Prevents Murine Systemic Sclerosis Through the Inhibition of Microparticle Shedding.

Kavian N, Marut W, Servettaz A, Nicco C, Chéreau C, Lemaréchal H, Guilpain P, Chimini G, Galland F, Weill B, Naquet P, Batteux F.

Arthritis Rheumatol. 2015 Jul;67(7):1881-90. doi: 10.1002/art.39121.

10.

[Methadone-induced edema: A case report].

Sarica A, Servettaz A, Abou Taam M, Herlem E, Carlier C, Trenque T.

Presse Med. 2015 May;44(5):552-4. doi: 10.1016/j.lpm.2014.12.005. Epub 2015 Mar 6. French. No abstract available.

PMID:
25753962
11.

[Chronic meningoencephalitis with dementia].

Daelman L, Garcia T, Servettaz A, Tourbah A.

Rev Neurol (Paris). 2014 Jun-Jul;170(6-7):465-7. doi: 10.1016/j.neurol.2014.02.005. Epub 2014 Apr 13. French. No abstract available.

PMID:
24726435
12.

The natural organosulfur compound dipropyltetrasulfide prevents HOCl-induced systemic sclerosis in the mouse.

Marut W, Jamier V, Kavian N, Servettaz A, Winyard PG, Eggleton P, Anwar A, Nicco C, Jacob C, Chéreau C, Weill B, Batteux F.

Arthritis Res Ther. 2013 Oct 28;15(5):R167. doi: 10.1186/ar4351.

13.

Control of humoral immunity and auto-immunity by the CXCR4/CXCL12 axis in lupus patients following influenza vaccine.

Launay O, Paul S, Servettaz A, Roguet G, Rozenberg F, Lucht F, Lambert C, Presles E, Goulvestre C, Méritet JF, Galtier F, Dubray C, Lebon P, Weill B, Batteux F.

Vaccine. 2013 Aug 2;31(35):3492-501. doi: 10.1016/j.vaccine.2013.05.095. Epub 2013 Jun 11.

14.

Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade.

Marut W, Kavian N, Servettaz A, Hua-Huy T, Nicco C, Chéreau C, Weill B, Dinh-Xuan AT, Batteux F.

Arthritis Rheum. 2013 May;65(5):1367-77. doi: 10.1002/art.37873.

15.

New insights into the mechanism of notch signalling in fibrosis.

Kavian N, Servettaz A, Weill B, Batteux F.

Open Rheumatol J. 2012;6:96-102. doi: 10.2174/1874312901206010096. Epub 2012 Jun 15.

16.

Reactive oxygen species-mediated killing of activated fibroblasts by arsenic trioxide ameliorates fibrosis in a murine model of systemic sclerosis.

Kavian N, Marut W, Servettaz A, Nicco C, Chéreau C, Lemaréchal H, Borderie D, Dupin N, Weill B, Batteux F.

Arthritis Rheum. 2012 Oct;64(10):3430-40. doi: 10.1002/art.34534.

17.

Arsenic trioxide prevents murine sclerodermatous graft-versus-host disease.

Kavian N, Marut W, Servettaz A, Laude H, Nicco C, Chéreau C, Weill B, Batteux F.

J Immunol. 2012 May 15;188(10):5142-9. doi: 10.4049/jimmunol.1103538. Epub 2012 Apr 9.

18.

The organotelluride catalyst (PHTE)₂NQ prevents HOCl-induced systemic sclerosis in mouse.

Marut WK, Kavian N, Servettaz A, Nicco C, Ba LA, Doering M, Chéreau C, Jacob C, Weill B, Batteux F.

J Invest Dermatol. 2012 Apr;132(4):1125-32. doi: 10.1038/jid.2011.455. Epub 2012 Jan 26.

19.

Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor β in the skin of mice with scleroderma-like features and prevents the development of the disease.

Kavian N, Servettaz A, Marut W, Nicco C, Chéreau C, Weill B, Batteux F.

Arthritis Rheum. 2012 Jun;64(6):1990-2000. doi: 10.1002/art.34354. Epub 2011 Dec 27.

20.

New insights on chemically induced animal models of systemic sclerosis.

Batteux F, Kavian N, Servettaz A.

Curr Opin Rheumatol. 2011 Nov;23(6):511-8. doi: 10.1097/BOR.0b013e32834b1606. Review.

PMID:
21857225

Supplemental Content

Loading ...
Support Center